RENE DEL BOSQUE: Open Payments
NPI 1528493459 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 30 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $217 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
| Lundbeck LLC | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $24 |
| Phadia US Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
Products named: VRAYLAR, REXULTI, AUSTEDO XR, Auvelity, CAPLYTA, UZEDY, INGREZZA, Onyda XR.
Industry payments across TX — which companies pay providers there.
